Results 11 to 20 of about 3,225,994 (369)
Angiogenesis Inhibitors in NSCLC. [PDF]
Int J Mol Sci, 2017 Angiogenesis is a complex biological process that plays a relevant role in sustaining the microenvironment, growth, and metastatic potential of several tumors, including non-small cell lung cancer (NSCLC). Bevacizumab was the first angiogenesis inhibitor
Manzo A +10 more
europepmc +6 more sources
Editorial: Angiogenesis and Angiogenesis Inhibitors in Oral Cancer [PDF]
Frontiers in Oral Health, 2021 Non peer ...
Abdelhakim Salem +5 more
doaj +6 more sources
Endogenous inhibitors of angiogenesis [PDF]
Journal of Cell Science, 2001 In the course of embryonic development, during some normal physiological processes in the adult, such as the female reproductive cycle, and also in a variety of pathologies, including tumour growth, new blood vessels develop from the pre-existing vascular network through endothelial cell sprouting,
Christiana Ruhrberg
core +8 more sources
Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma [PDF]
Frontiers in Pharmacology, 2016 Background: Angiogenesis inhibitors have become an important therapeutic approach in the treatment of hepatocellular carcinoma (HCC) patients. The therapeutic inhibition of angiogenesis of Sorafenib in increasing overall survival of patients with HCC is ...
M. Berretta +7 more
semanticscholar +8 more sources
Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
Marine Drugs, 2013 Angiogenesis inhibitors have been successfully used for cancer therapy in the clinic. Many marine-derived natural products and their analogues have been reported to show antiangiogenic activities.
Ying-Qing Wang, Ze-Hong Miao
doaj +2 more sources
The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer [PDF]
Cancer Medicine, 2019 Background Small cell lung cancer (SCLC) is a highly invasive and lethal neuroendocrine tumor. Antiangiogenic drugs have been reported in the treatment of SCLC. We aimed to provide a comprehensive evaluation of the impact of angiogenic inhibitors on SCLC
Xiaoshun Shi +10 more
doaj +2 more sources
Angiogenesis inhibitors. [PDF]
Journal of Thoracic Oncology, 2012 M. Das, H. Wakelee
semanticscholar +6 more sources
An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis
Scientific Reports, 2023 Malignant cancer angiogenesis has historically attracted enormous scientific attention. Although angiogenesis is requisite for a child’s development and conducive to tissue homeostasis, it is deleterious when cancer lurks.
Syed Anas Ansar +5 more
doaj +1 more source
Journal of Dental Sciences, 2021 Background/purpose: The prevalence of oral adverse events and dental treatments related complications during the molecular targeted drugs therapy remains unclear.
Shin-ichi Yamada +8 more
doaj +1 more source
Thalidomide is an inhibitor of angiogenesis. [PDF]
Proceedings of the National Academy of Sciences, 1994 Thalidomide is a potent teratogen causing dysmelia (stunted limb growth) in humans. We have demonstrated that orally administered thalidomide is an inhibitor of angiogenesis induced by basic fibroblast growth factor in a rabbit cornea micropocket assay.
Michael S. Loughnan +3 more
openaire +4 more sources